title: Methotrexate-induced leukoencephalopathy reversed by aminophylline and high-dose folinic acid.
authors.affiliation: Department of Haematology/Oncology, Queen Elizabeth Hospital, Woodville, Australia. jaksic@chariot.net.au
authors.forename: Wilfrid
authors.initials: W
authors.lastname: Jaksic
authors.forename: Dusan
authors.initials: D
authors.lastname: Veljkovic
authors.forename: Chris
authors.initials: C
authors.lastname: Pozza
authors.forename: Ian
authors.initials: I
authors.lastname: Lewis
mesh_terms: D000328:Adult; D000628:Aminophylline / Q000008:administration & dosage* / Q000627:therapeutic use; D001927:Brain Diseases / Q000139:chemically induced* / Q000175:diagnosis / Q000188:drug therapy; D005260:Female; D006801:Humans; D002955:Leucovorin / Q000008:administration & dosage* / Q000627:therapeutic use; D008279:Magnetic Resonance Imaging; D008727:Methotrexate / Q000009:adverse effects*; D020258:Neurotoxicity Syndromes / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D015452:Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / Q000150:complications / Q000188:drug therapy; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000150:complications / Q000188:drug therapy; D016896:Treatment Outcome
chemical_list: D000628:Aminophylline; D002955:Leucovorin; D008727:Methotrexate